NCT00321464 2022-11-08
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Amgen
Phase 3 Completed
Amgen
Finnish Breast Cancer Group
Monash University
University of Wisconsin, Madison
University of Aarhus
AstraZeneca